Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03730649 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
A Early Phase 1 study of Skin Aging, sponsored by Johns Hopkins University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03730649 is a Early Phase 1 study of Skin Aging that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 12 participants, below the 74-participant average among 9 other Skin Aging trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03730649, a Early Phase 1 study of Skin Aging, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to compare the expression of both keratin 16 and 17 before and after application of sulforaphane on both photoprotected and photoexposed area, and to determine whether these findings alter skin aging as well as skin response to ultraviolet (UV) and visible light exposure.
Conditions Studied
Interventions
- DRUG Sulforaphane (broccoli sprout extract)
- RADIATION UV or visible light
Study Locations (1)
Maryland
- Cutaneous Translational Research Program, Department of Dermatology, Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-10-09 |
| Est. Completion | 2026-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03730649
The ClinicalTrials.gov registry entry for NCT03730649 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 9 other Skin Aging trials with a reported enrollment target (84% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Aging appearing as the primary indexed condition, and to 2 interventions - of which Sulforaphane (broccoli sprout extract) is the first listed.
NCT03730649 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03730649 about?
NCT03730649 is a clinical study titled "Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure". The study is to compare the expression of both keratin 16 and 17 before and after application of sulforaphane on both photoprotected and photoexposed area, and to determine whether these findings alter skin aging as well as skin response to ultraviolet (UV) and visible light exposure.
What is the current status of trial NCT03730649?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2019-10-09. Estimated completion is 2026-10.
What conditions does trial NCT03730649 study?
This clinical trial studies the following conditions: Skin Aging.
What interventions are being tested in trial NCT03730649?
The interventions under investigation include: Sulforaphane (broccoli sprout extract) (DRUG), UV or visible light (RADIATION).
Who is sponsoring clinical trial NCT03730649?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03730649 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
-
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.